Home

Kenneth T. Mills, President and CEO: Regenxbio RGNX Sell · Filed 24/04/17

Trade details

Type
Insider sale
Amount
$272,850
Shares · price
15,000 sh · $18.19 a share
Held after
408,035 sh
Trade date
24/04/15
Filed
24/04/17
Days to filing
2 days

Sold 3.5% of holdings

Share of holding sold
3.5%

Regenxbio trades, last 26 weeks

What else happened in Regenxbio around then

Filed or reported within 30 days of the trade day · 24/03/16~24/05/15

Kenneth T. Mills's recent trades

  • Kenneth T. Mills

    Sell10b5-1 planRegenxbio

    $163K

    Filed 25/05/14

  • Kenneth T. Mills

    Planned sale10b5-1 planRegenxbio

    $154.9K

    Filed 25/05/12

  • Kenneth T. Mills

    Sell10b5-1 planRegenxbio

    $214.6K

    Filed 24/07/26

  • Kenneth T. Mills

    Sell10b5-1 planRegenxbio

    $168.4K

    Filed 24/07/26

  • Kenneth T. Mills

    Sell10b5-1 planRegenxbio

    $30.4K

    Filed 24/07/18

Kenneth T. Mills, CEO — sold $272.9K of Regenxbio RGNX · 3.5% of holdings · 10b5-1 plan | Whalegun